Prostacyclin receptor agonist selexipag in a patient with high-risk idiopathic pulmonary arterial hypertension: a case report

We present a 48-year-old patient with World Health Organization class III idiopathic pulmonary arterial hypertension (IPAH), taking specific therapy with macitentan 10 mg a day, who was readmitted to the National Medical Research Center of Cardiology due to increase in exercise dyspnea and decrease...

Full description

Bibliographic Details

Published in:	Кардиоваскулярная терапия и профилактика
Main Authors:	E. A. Rezukhina, O. V. Rodnenkov, T. V. Martynyuk
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2021-09-01
Subjects:	pulmonary arterial hypertension idiopathic pulmonary hypertension prostacyclin receptor agonist selexipag
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/3010